Eli Lilly (LLY) Q2 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/08/08/eli-lilly-lly-q2-2024-earnings-call-transcript/?source=iedfolrf0000001
Aug 08, 2024 - LLY earnings call for the period ending June 30, 2024.
0
Eli Lilly: The Next $1 Trillion Market Cap Stock?
https://www.zacks.com/commentary/2319475/eli-lilly-the-next-1-trillion-market-cap-stock?cid=CS-ZC-FT-investment_ideas-2319475
Aug 08, 2024 - Eli Lilly showcased the exceptional strength of its business during its quarterly earnings meeting on Thursday morning
0
Eli Lilly vs Novo Nordisk: A Recent Study Suggests This Company Has the Best Weight Loss Drug
https://www.fool.com/investing/2024/08/03/eli-lilly-vs-novo-nordisk-a-recent-study-suggests/?source=iedfolrf0000001
Aug 03, 2024 - These healthcare stocks are up more than 400% in the past five years, thanks to their dominance in the anti-obesity market.
0
Home Depot Stock Turned $1,000 Into $17.5 Million, and One of Its Founders Just Revealed His Investing Secrets to Achieve Generational Wealth
https://www.fool.com/investing/2024/07/28/home-depot-stock-turned-1000-into-175-million-and/?source=iedfolrf0000001
Jul 28, 2024 - Home Depot founder Ken Langone recently shared his investment wisdom on the American Optimist podcast.
0
These 2 Growth Stocks Are Set to Soar This Summer and Beyond
https://www.fool.com/investing/2024/07/27/these-2-growth-stocks-are-set-to-soar-this-summer/?source=iedfolrf0000001
Jul 27, 2024 - It's a great time to invest in wonderful stocks.
0
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
https://www.fool.com/investing/2024/07/27/bull-market-buys-2-growth-stocks-to-own-for-the/?source=iedfolrf0000001
Jul 27, 2024 - These companies are no strangers to beating the market.
0
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
https://www.zacks.com/stock/news/2306385/eli-lilly-lly-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2306385
Jul 22, 2024 - In the most recent trading session, Eli Lilly (LLY) closed at $865.97, indicating a +0.99% shift from the previous trading day.
0
Novo Nordisk, Lilly Slide on Roche's Obesity Drug Study Data
https://www.zacks.com/stock/news/2304649/novo-nordisk-lilly-slide-on-roche-s-obesity-drug-study-data?cid=CS-ZC-FT-analyst_blog|industry_focus-2304649
Jul 18, 2024 - Shares of obesity drugmakers Novo Nordisk (NVO) and Eli Lilly (LLY) lost market value on Wednesday after Roche (RHHBY) released positive early-stage data from a study on its obesity drug candidate.
0
FDA Accepts Lexicon's (LXRX) NDA for Type I Diabetes Drug
https://www.zacks.com/stock/news/2303768/fda-accepts-lexicon-s-lxrx-nda-for-type-i-diabetes-drug?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2303768
Jul 17, 2024 - The FDA accepts Lexicon's (LXRX) resubmission seeking approval for sotagliflozin to treat adults with type 1 diabetes. A final decision is expected by Dec 20.
0
3 Unstoppable Stocks That You Can Buy and Hold for Years
https://www.fool.com/investing/2024/07/17/3-unstoppable-stocks-that-you-can-buy-and-hold-for/?source=iedfolrf0000001
Jul 17, 2024 - These blue chip stocks are leaders within their respective industries.
0